touchHEMATOLOGY

📢 Lymphoma at ASCO 2026: Six key abstracts At #ASCO2026, several pivotal studies provided new insights across the lymphoma treatment landscape, spanning newly diagnosed and relapsed/refractory disease. In this expert commentary, touchHEMATOLOGY Editorial Board member Dr Tycel Phillips highlights six of the most important abstracts from the meeting and discusses their potential impact on future clinical practice. Discover the key advances shaping the future of lymphoma care. 🔗 Read more: touchhaematology.com/insight… #Lymphoma #Hematology #ASCO2026 #BloodCancer #CancerResearch

📢 EBMT 2026: Highlights from the 52nd Annual Meeting In proud collaboration with EBMT, we bring you key highlights from the 52nd Annual Meeting (EBMT 2026), showcasing the latest advances in transplant and cellular therapies. Hear from leading voices including Dr Anna Sureda (EBMT President) and Dr Rafael Duarte (Congress President) on the power of collaboration, innovation and rapid progress across the field. This year’s coverage spans cutting-edge developments, including CAR-T monitoring using AI, gene therapy in primary immunodeficiencies, novel approaches in graft-versus-host disease, advances in multiple myeloma treatment, and emerging therapies for refractory viral infections. Explore the highlights: touchhaematology.com/insight… #EBMT2026 #Hematology #Transplantation #CellularTherapy #CART #GeneTherapy

👀 Not following us yet? Here’s what you’re missing… Our social channels are where you’ll find the stuff worth stopping your scroll for. 🎓 Keep up with expert-led medical education 🔬 Explore the latest clinical insights and developments 🎥 Hear directly from leading healthcare professionals 🌍 Connect with perspectives from across the global medical community 📚 Discover educational content designed to support your ongoing learning 🔔 Be among the first to see our latest videos, articles and expert discussions And that’s just the beginning. We’re building a community we want you to be part of; so don’t just scroll past… 👉 Hit follow and come join us. Already following? Tag someone who should be too! 👇 #MedicalEducation #MedEd #HealthcareProfessionals #MedicalLearning #ClinicalEducation #Healthcare

🚀 From microscope to machine learning: Scaling CAR-T monitoring with AI At EBMT 2026, Dr Roni Shouval (Memorial Sloan Kettering Cancer Center) shared how his team is turning routine blood smears into a high-throughput, AI-powered platform for tracking immune responses after CAR-T therapy. This approach could make immune monitoring faster, more scalable, and more personalised - giving clinicians better insight into patient outcomes over time. Read the Q&A: touchhaematology.com/insight… #CAR-T #Immunotherapy #AIinMedicine #EBMT2026 #Hematology #PrecisionMedicine

What's next for AL amyloidosis treatment? Explore MDT treatment decisions: cardiac and renal care, frailty, and the potential role of fibril-directed therapies alongside plasma-cell–directed treatment. 🎓 Earn CME credit: touchhaematologyime.org/card… #ALAmyloidosis #MedEd

🫀 AL or ATTR? Explore clinical and imaging red flags, monoclonal-protein testing, biopsy and amyloid typing, including when to prioritize ruling out AL. 🎓 Watch now to earn CME credit: touchhaematologyime.org/card… #CardiacAmyloidosis #MedEd

💡 Unlock the latest in Haematology research! Stay up-to-date with the newest insights, clinical advancements, and expert opinions in blood disorders and treatments. Subscribe to the touchHAEMATOLOGY platform today and be the first to know! 🌟 Get exclusive access to research summaries, treatment updates, and more—all tailored for healthcare professionals. Ready to level up your knowledge? 📬 Register now: touchhaematology.com/your-fr… #Haematology #BloodHealth #MedicalNews

🩸 What could emerging cell therapies mean for older adults with relapsed or refractory acute myeloid leukaemia? A new review explores the challenges associated with relapsed/refractory AML in older adults and examines emerging cell therapy approaches, including adaptations to conditioning strategies for haematopoietic stem cell transplantation. 🔎 The review considers the potential of these approaches, alongside the clinical challenges that can influence treatment outcomes. Read the full review: touchhaematology.com/leukemi… #AML #AcuteMyeloidLeukaemia #Haematology #CellTherapy #BloodCancer

🩺 Stay curious. Stay informed. Stay connected. Medicine never stands still and neither should your knowledge. Follow touchHEMATOLOGY and make your feed a destination for trusted medical education, expert perspectives and the latest thinking across a wide range of therapy areas. Why follow us? 🎓 Keep up with expert-led medical education 🔬 Explore the latest clinical insights and developments 🎥 Hear directly from leading healthcare professionals 🌍 Connect with perspectives from across the global medical community 📚 Discover educational content designed to support your ongoing learning 🔔 Be among the first to see our latest videos, articles and expert discussions Your feed. More informed. Follow touchHEMATOLOGY and stay connected to the conversations shaping medicine. #MedicalEducation #MedEd #HealthcareProfessionals #MedicalLearning #ClinicalEducation #Healthcare

🩸 What developments are shaping the future of malignant hematology? From T-cell-engaging therapies to earlier disease intervention and new approaches to understanding disease biology, treatment is becoming increasingly targeted across a range of hematological malignancies. 🔎 Explore five developments making headlines across acute lymphoblastic leukaemia, multiple myeloma, follicular lymphoma and polycythaemia vera. Read the full article: touchhaematology.com/insight… #Hematology #MalignantHematology #BloodCancer #Oncology #MedicalEducation

🌟 Exciting news! 🌟 🎙️ Our podcast series Visionary Voices is now on Spotify! 🎙️ Join us and our incredible guests as we explore key trends, innovations and the stories shaping the pharmaceutical and healthcare industries. 🎧 Ready to tune in? Click below to explore our episodes! 👉 Listen now on Spotify: open.spotify.com/show/6RG0gK… #Podcast #VisionaryVoices #HealthcareInnovation #TouchMedicalMedia

🔬 Explore the standout advances from #EHA2026. Our comprehensive round-up highlights the most impactful data from the Plenary, Late-breaking, EHA Awards and top oral sessions, with expert perspectives across the full spectrum of hematology. From leukemia and lymphoma to myeloma and non-malignant blood disorders, discover the studies and insights that could shape future clinical practice. Read more: touchhaematology.com/insight… #EHA2026 #Hematology #BloodCancer #Leukemia #Lymphoma #Myeloma

Have you seen our latest #YouTube video? ‘Systemic mastocytosis: Making the right decisions at the right time’ Watch now: youtu.be/y3gGeb8-aCw #SystemicMastocytosis #Mastocytosis #Anaphylaxis #Hematology #Allergy #CME #MedEd #HCP

🫀 AL or ATTR? Getting the diagnosis right matters. Explore stepwise diagnosis, the role of multidisciplinary teams and emerging AL therapies in cardiac amyloidosis. 🎓 Gain expert insights & earn CME credit: touchhaematologyime.org/card… #CardiacAmyloidosis #MedEd

🆕 How can clinicians optimise risk assessment and management in high-risk multiple myeloma? In the latest Hematology Horizons practice pearl, Dr Saurabh Zanwar (Mayo Clinic, Rochester) explores the evolving approach to identifying and managing high-risk disease. Discover how multidimensional risk assessment, treatment intensification across the treatment pathway and longitudinal measurable residual disease (MRD) monitoring can inform clinical decision-making, alongside emerging immune-based strategies. 🔎 Read the full practice pearl: touchhaematology.com/insight… #Haematology #MultipleMyeloma #CancerCare #MRD #MedicalEducation

🆕 How close are we to translating microbiome research into routine oncology practice? In a new Q&A on touchONCOLOGY, Prof Hannah Wardill and Dr Maya Davies (Adelaide University, South Australia) discuss findings from an international survey exploring healthcare professionals’ knowledge, perceptions and practices relating to the gut microbiome in cancer care. Explore current approaches to probiotics, faecal microbiota transplantation and antibiotic decision-making, alongside the safety, practical and infrastructure challenges that must be addressed to translate emerging evidence into meaningful clinical interventions. 🔎 Read the full Q&A: touchhaematology.com/insight… #Oncology #CancerResearch #Microbiome #PrecisionOncology #MedicalEducation

🆕 How should clinicians approach frontline treatment selection in chronic lymphocytic leukaemia (CLL)? In the latest Hematology Horizons practice pearl, Dr Alexey Danilov (City of Hope National Medical Center, USA) explores the key considerations when choosing between time-limited and continuous targeted therapies. Discover how disease biology, including TP53 disruption and IGHV mutation status, alongside comorbidities, treatment logistics, toxicity and patient preferences, can help inform treatment decisions. 🔎 Read the full practice pearl: touchhaematology.com/insight… #Haematology #CLL #Leukaemia #CancerCare #MedicalEducation

🆕 How can clinicians improve the recognition and management of transplant-associated thrombotic microangiopathy (TA-TMA)? In the latest Hematology Horizons practice pearl, Dr Eleni Gavriilaki (Aristotle University of Thessaloniki, Greece) shares practical guidance on identifying TA-TMA following haematopoietic cell transplantation. Explore key clinical and laboratory parameters, approaches to distinguishing TA-TMA from other post-transplant complications, risk stratification and the evolving role of complement-directed therapy in high-risk disease. 🔎 Read the full practice pearl: touchhaematology.com/insight… #Haematology #TATMA #StemCellTransplantation #TransplantMedicine #MedicalEducation

🩺 Supporting the future of hematology nursing At EHA 2026, Erik Aerts, President of the Hematology Nurses & Healthcare Professionals Group (HNHCP), discusses how the role of hematology nurses is evolving alongside advances in cellular therapies and personalized care. From expanding educational opportunities and strengthening international collaboration to addressing workforce challenges and supporting multidisciplinary care, discover how HNHCP is helping prepare the hematology nursing community for the future. Read: touchhaematology.com/insight… #EHA2026 #Hematology #Nursing #HealthcareProfessionals #MedicalEducation

🏆 Recognizing a legacy of discovery in hematology Following receipt of the EHA 2026 Research Excellence Award, Prof George Vassiliou reflects on the scientific milestones that have shaped our understanding of clonal hematopoiesis, myeloid malignancies and AML. Explore his insights into the future of prevention-focused hematology, early intervention strategies and the next generation of precision research. Read more on touchHEMATOLOGY: touchhaematology.com/insight… #EHA2026 #Hematology #AML #ClonalHematopoiesis #Research